Identification of CVID patients with defects in immune repertoire formation or specification by Van Schouwenburg, P, Ijspeert, H, Pico-Knijnenburg, I, Dalm, V, Van Hagen, P, Van Zessen, D, Stubbs, A, Patel, S, Van Der Burg, M

The immune response in tubercular uveitis and its implications for treatment: from anti-tubercular treatment to host-directed therapies by Putera, Ikhwanuliman, Schrijver, Benjamin, ten Berge, Josianne C. E. M., Gupta, Vishali, Nora, Rina La Distia, Agrawal, Rupesh, van Hagen, P. Martin, Rombach, Saskia M., Dik, Willem A.

Get full text

Clinical features and predictors of treatment outcome in patients with ocular tuberculosis from the Netherlands and Indonesia: the OculaR TB in low versus high endemic countries (O... by Putera, Ikhwanuliman, ten Berge, Josianne C. E. M., Thiadens, Alberta A. H. J., Dik, Willem A., Agrawal, Rupesh, van Hagen, P Martin, La Distia Nora, Rina, Rombach, Saskia M.

Get full text

Relapse in ocular tuberculosis: relapse rate, risk factors and clinical management in a non-endemic country by Putera, Ikhwanuliman, ten Berge, Josianne C. E. M., Thiadens, Alberta A. H. J., Dik, Willem A., Agrawal, Rupesh, van Hagen, P. Martin, La Distia Nora, Rina, Rombach, Saskia M.

Get full text

Diagnosis and biomarkers for ocular tuberculosis: from the present into the future by Ludi, Zhang, Sule, Ashita Ashish, Samy, Ramar Perumal, Putera, Ikhwanuliman, Schrijver, Benjamin, Hutchinson, Paul Edward, Gunaratne, Jayantha, Verma, Indu, Singhal, Amit, Nora, Rina La Distia, van Hagen, P. Martin, Dik, Willem A., Gupta, Vishali, Agrawal, Rupesh

Get full text

A serum B-lymphocyte activation signature is a key distinguishing feature of the immune response in sarcoidosis compared to tuberculosis by Putera, Ikhwanuliman, Schrijver, Benjamin, Kolijn, P. Martijn, van Stigt, Astrid C., Ten Berge, Josianne C. E. M., IJspeert, Hanna, Nagtzaam, Nicole M. A., Swagemakers, Sigrid M. A., van Laar, Jan A. M., Agrawal, Rupesh, Rombach, Saskia M., van Hagen, P. Martin, La Distia Nora, Rina, Dik, Willem A.

Get full text

Strength and weakness of B cell phenotype based classification of patients with common variable immunodeficiency. by Warnatz, K, Wehr, C, Schmitt, C, Ferry, B, Witte, T, Eren, E, Hernandez, M, Detkova, D, Litzman, J, Rosado, M, Bos, P, Poerksen, G, von Bernuth, H, Baumann, U, Gameiro, C, Cruyssen, F, Le Graff, M, Vlkova, M, Jacobs, R, Jones, J, Bateman, E, Gutenberger, S, Schlesier, M, van Hagen, P, Carsetti, R

The EUROclass trial: defining subgroups in common variable immunodeficiency. by Wehr, C, Kivioja, T, Schmitt, C, Ferry, B, Witte, T, Eren, E, Vlkova, M, Hernandez, M, Detkova, D, Bos, P, Poerksen, G, von Bernuth, H, Baumann, U, Goldacker, S, Gutenberger, S, Schlesier, M, Bergeron-van der Cruyssen, F, Le Garff, M, Debré, P, Jacobs, R, Jones, J, Bateman, E, Litzman, J, van Hagen, P, Plebani, A